Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: A population-based study

Lauren C. Harshman, Wanling Xie, Georg A. Bjarnason, Jennifer J. Knox, Mary MacKenzie, Lori Wood, Sandy Srinivas, Ulka N. Vaishampayan, Min Han Tan, Sun Young Rha, Frede Donskov, Neeraj Agarwal, Christian Kollmannsberger, Scott North, Brian I. Rini, Daniel Y.C. Heng, Toni K. Choueiri

Research output: Contribution to journalArticlepeer-review

108 Citations (Scopus)
Original languageEnglish
Pages (from-to)927-935
Number of pages9
JournalThe Lancet Oncology
Volume13
Issue number9
DOIs
Publication statusPublished - Sept 2012
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology

Fingerprint

Dive into the research topics of 'Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: A population-based study'. Together they form a unique fingerprint.

Cite this

Harshman, L. C., Xie, W., Bjarnason, G. A., Knox, J. J., MacKenzie, M., Wood, L., Srinivas, S., Vaishampayan, U. N., Tan, M. H., Rha, S. Y., Donskov, F., Agarwal, N., Kollmannsberger, C., North, S., Rini, B. I., Heng, D. Y. C., & Choueiri, T. K. (2012). Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: A population-based study. The Lancet Oncology, 13(9), 927-935. https://doi.org/10.1016/S1470-2045(12)70285-1